AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2005
Sep 29, 2005
34117_dirs_2005-09-29_640eb753-7077-4f93-9014-861a4a5d0fc9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2005-09-27
Reporting Person: HERMS HENRY P (Director, V.P. Finance & C.F.O.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-09-27 | Common Stock | A | 16025 | $0.00 | Acquired | 31025 | Direct |
| 2005-09-28 | Common Stock | S | 10000 | $0.50 | Disposed | 31025 | Direct |
Footnotes
F1: Award, pursuant to the Copytele, Inc. 2003 Share Incentive Plan.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6